Literature DB >> 7424951

Invasive pulmonary aspergillosis in an apparently nonimmunocompromised host.

E Brown, S Freedman, R Arbeit, S Come.   

Abstract

Invasive aspergillosis generally occurs in patients with hematologic malignancies, neutropenia or other severe derangements of host defense. An adult patient without such a predisposition, and without a previous history of susceptibility to infections, had rapidly progressive respiratory failure associated with repeated growth of Aspergillus fumigatus on culture of sputum and bronchoscopy specimens. At autopsy he proved to have invasive pulmonary aspergillosis.

Entities:  

Mesh:

Year:  1980        PMID: 7424951     DOI: 10.1016/0002-9343(80)90478-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease.

Authors:  L B Palmer; H E Greenberg; M J Schiff
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

2.  Clinicopathological patterns of invasive and superficial fungal infection.

Authors:  G S McDonald; P Crowe
Journal:  Ir J Med Sci       Date:  1988-06       Impact factor: 1.568

Review 3.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 4.  Aspergillosis.

Authors:  G P Bodey; S Vartivarian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

5.  Invasive aspergillosis in a "healthy" patient.

Authors:  K J Ascah; R H Hyland; M A Hutcheon; S J Urbanski; W Pruzanski; E L St Louis; D P Jones; E C Keystone
Journal:  Can Med Assoc J       Date:  1984-08-15       Impact factor: 8.262

6.  Case report 750: Aspergillosis of the chest wall in an apparently immunocompetent host.

Authors:  M S Fisher
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

7.  Disseminated aspergillosis in a patient with ocular reticulum cell sarcoma.

Authors:  T M Bosley; K J Kaufman; R Folberg; R C Sergott; P J Savino; J B Belmont
Journal:  Br J Ophthalmol       Date:  1987-07       Impact factor: 4.638

8.  Primary lymph node invasive aspergillosis.

Authors:  A Mazzoni; M Ferrarese; R Manfredi; A Facchini; C Sturani; A Nanetti
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

9.  Defective phagocyte Aspergillus killing associated with recurrent pulmonary Aspergillus infections.

Authors:  A Fietta; F Sacchi; P Mangiarotti; G Manara; G Gialdroni Grassi
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

10.  Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression.

Authors:  J R Graybill; R Bocanegra; L K Najvar; D Loebenberg; M F Luther
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.